We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
-3.87%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$34.7M
AUM Growth
-$94.8M
Cap. Flow
-$17.4M
Cap. Flow %
-50.11%
Top 10 Hldgs %
53.9%
Holding
92
New
11
Increased
15
Reduced
20
Closed
39

Sector Composition

Rank Sector Weight
1 Healthcare 56.98%
2 Miscellaneous 16.1%
3 Materials 7.31%
4 Technology 5.39%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEM icon
26
Newmont
NEM
$135B
$325K 0.94%
8,576
-3,000
-26% -$117K
ELGX
27
DELISTED
Endologix Inc
ELGX
$323K 0.93%
81,460
+42,379
+108% +$246K
TCON
28
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$321K 0.93%
3,589
+151
+4% +$15.5K
WFC icon
29
Wells Fargo
WFC
$262B
$312K 0.9%
6,180
+180
+3% +$8.48K
SRRA
30
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$307K 0.89%
19,669
+813
+4% +$15.6K
ADMA icon
31
ADMA Biologics
ADMA
$2.09B
$285K 0.82%
64,000
-47,005
-42% -$196K
B
32
Barrick Mining
B
$75.1B
$277K 0.8%
16,000
MTNB icon
33
Matinas BioPharma
MTNB
$2.94M
$272K 0.78%
8,631
-2,861
-25% -$103K
GS icon
34
Goldman Sachs
GS
$301B
$249K 0.72%
1,200
-800
-40% -$167K
ADP icon
35
Automatic Data Processing
ADP
$114B
$242K 0.7%
1,500
ACRS icon
36
Aclaris Therapeutics
ACRS
$885M
$232K 0.67%
214,593
+25,063
+13% +$35.6K
BID
37
DELISTED
Sotheby's
BID
$224K 0.65%
+3,925
New +$227K
BN icon
38
Brookfield
BN
$92.3B
$221K 0.64%
+11,676
New +$211K
GWR
39
DELISTED
Genesee & Wyoming Inc.
GWR
$221K 0.64%
+2,000
New +$220K
MSFT icon
40
Microsoft
MSFT
$3.81T
$209K 0.6%
1,500
-500
-25% -$68.8K
WBC
41
DELISTED
WABCO HOLDINGS INC.
WBC
$201K 0.58%
1,500
-11,100
-88% -$1.48M
GCI
42
DELISTED
Gannett Co., Inc
GCI
$189K 0.55%
+17,600
New +$175K
CDOR
43
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$172K 0.5%
+15,583
New +$163K
BLPH
44
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$163K 0.47%
22,533
-10,104
-31% -$92.1K
VSTM icon
45
Verastem
VSTM
$654M
$139K 0.4%
9,550
-2,533
-21% -$41.1K
ROSE
46
DELISTED
Rosehill Resources Inc. Class A
ROSE
$123K 0.35%
63,137
-7,210
-10% -$16.4K
SNDX icon
47
Syndax Pharmaceuticals
SNDX
$1.74B
$97K 0.28%
+13,000
New +$118K
ORMP icon
48
Oramed Pharmaceuticals
ORMP
$209M
$32K 0.09%
+10,000
New +$33.3K
ARTX
49
DELISTED
Arotech Corporation
ARTX
$29K 0.08%
+10,000
New +$22.1K
ROSEW
50
DELISTED
Rosehill Resources Inc.
ROSEW
$12K 0.03%
61,260

Similar funds

Telemetry Investments's Q3 2019 Portfolio in Review

As of Q3 2019, Telemetry Investments held 92 positions worth $34.7M, down 73% from $129M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Telemetry Investments withdrew a net $17.4M in Q3 2019, closing 39 positions and reducing 20 holdings. Its most notable exit was Red Hat Inc, an estimated $2.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Materials.

Against the trend, Telemetry Investments opened a new position in Allergan plc worth $1.97M.

  • Telemetry Investments's largest Q3 2019 buy was Allergan plc: 11,700 shares worth $1.97M.
  • Telemetry Investments added most to Celgene Corp in Q3 2019, an estimated $1.69M increase.
  • Telemetry Investments's biggest Q3 2019 reduction was Kadmon Holdings, Inc., cutting an estimated $2.78M.
  • Telemetry Investments fully exited Red Hat Inc in Q3 2019, selling an estimated $2.35M.
  • Telemetry Investments's ten largest holdings make up 54% of its $34.7M portfolio in Q3 2019.
  • Telemetry Investments opened 11 new positions and closed 39 in Q3 2019.
  • Telemetry Investments's portfolio value fell 73% quarter-over-quarter to $34.7M.

Based on Telemetry Investments's 13F filing for Q3 2019, filed 14 Nov 2019.